Boston, MA--TeaPot, a cannabis-infused iced tea brand under the Boston Beer Company Inc., broadens its horizons by launching its latest offering, Good Evening Iced Tea in Blueberry Chamomile.
Following the launch of its Mango Green Tea and Lemon Black Tea, the company has introduced a new Blueberry Chamomile variant to enhance the consumer's evening experiences. This new addition is enriched with Black Sugar Rose, an Indica-dominant strain developed by Entourage Health Corp. under their Color Cannabis brand.
The iced tea comes with 5mg of THC per 355mL can and is devoid of caffeine, ensuring a relaxing and calming sensation, ideal for unwinding after an arduous day. This non-carbonated iced tea is expertly crafted to mask cannabis taste or aroma.
A Refreshing Evening Alternative
Paul Weaver, the Head of Cannabis for The Boston Beer Company, said in a news release that the new Blueberry Chamomile Iced Tea is a delightful alternative to the usual evening glass of wine. This tea is low in sugar, caffeine-free, and alcohol-free, which, combined with a relaxing Indica strain, is poised to revolutionize evening tea consumption.
"Whether sipping by the fire or gazing at the stars, this Good Evening Iced Tea will end your day on a high note," said Weaver.
Availability
Initially, Tye Blueberry Chamomile Tea will be available online in Ontario at select dispensaries. The tea is produced at Peak Processing Solutions and distributed by Entourage Health Corp. in Ontario.
About TeaPot and The Boston Beer Company
Established in 1984, The Boston Beer Company Inc. is revered for brewing the Samuel Adams beer. It's also acclaimed for its brands like Truly Hard Seltzer, Twisted Tea, Angry Orchard Hard Cider, and Dogfish Head Brewery.
In 2021, the company created a dedicated research and innovation hub, BBCCC Inc., focusing on non-alcoholic cannabis beverages.
TeaPot, the first cannabis-infused product line from BBCCC Inc., seeks to pair the right tea with the right cannabis strain for the right occasion, ensuring a consistent drinking experience.
Massachusetts cannabis market
According to the Massachusetts Cannabis Control Commission (CCC), cannabis shoppers and medical patients spent nearly $1.8 billion at Massachusetts dispensaries in 2022, representing 7% year-over-year growth.
Massachusetts’ 2022 adult-use cannabis sales were also up big compared to the first five months of 2021, but May figures represent a seasonal plateau in the state market.
Adult-use retailers reported more than $120 million in May 2022 sales, bringing the state’s yearly total to $585.6 million, representing a 20.7% increase from the $485.2 million sales during the same timeframe in 2021.